Search Results for: Neurosense

Double boost for potential ALS treatment

The US FDA has given Orphan drug status to the PrimeC ALS therapy from Israel’s NeuroSense (see here). Meanwhile, NeuroSense has begun Phase 1 human clinical trials of PrimeC at two US sites and a Phase 2a human trial at … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Over one thousand backers for ALS therapy developer

I reported previously (Mar 2017) on Israel’s NeuroSense, which is developing a treatment for amyotrophic lateral sclerosis (ALS). NeuroSense has just raised NIS 4 million from over 1,100 backers in a crowdfunding campaign. https://www.calcalistech.com/ctech/articles/0,7340,L-3767719,00.html

Posted in Economy & Business | Leave a comment

New treatment for ALS

Israel’s NeuroSense Therapeutics is developing a treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It is based on a discovery by Weizmann Institute Professor Eran Hornstein of a micro-RNA molecule lacking in the muscles of ALS … Continue reading

Posted in Israel's Medical Achievements | Leave a comment